Literature DB >> 30859398

Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.

Toshiki Yamada1, Takeshi Hara2,3, Naoe Goto2, Hitoshi Iwata4, Hisashi Tsurumi5,6.   

Abstract

Follicular lymphoma (FL) is an indolent lymphoma that often transforms into a high-grade lymphoma, mostly diffuse large B-cell lymphoma. A case of FL suggested to transform into plasmablastic lymphoma is presented. A 59-year-old man was admitted to our hospital because of right lower abdominal pain and vomiting. Computed tomography showed a mass in the ileocecum. Colonoscopy showed a mass with an ulcer in the ascending colon, and surgery was performed. Immunohistochemical staining of the biopsied mass showed infiltrated lymphocytes that were positive for CD38, CD45, CD138, and λ chain, and negative for CD4, CD5, CD8, CD10, CD20, CD56, and κ chain. Flow cytometric analysis of the ascites showed similar results. FISH analyses performed using lymph node biopsy specimens, ascite fluid and pleural effusion fluid identified the presence of an IGH/BCL2 translocation. FL was suggested to transform into PBL. Although the patient received three courses of R-CHOP chemotherapy and salvage chemotherapy, the patient died because of lymphoma progression less than 6 months after the diagnosis of PBL. Transformation of FL to PBL is highly unusual. The lack of a standard treatment for PBL results in the poor outcome of this entity. Novel therapeutic approaches are needed.

Entities:  

Keywords:  Follicular lymphoma; Plasmablastic lymphoma; Transformation

Mesh:

Substances:

Year:  2019        PMID: 30859398     DOI: 10.1007/s12185-019-02591-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  Precursor B-lymphoblastic transformation of grade I follicle center lymphoma.

Authors:  S H Kroft; R Domiati-Saad; W G Finn; D B Dawson; B Schnitzer; T P Singleton; C W Ross
Journal:  Am J Clin Pathol       Date:  2000-03       Impact factor: 2.493

2.  Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases.

Authors:  Y Natkunam; R A Warnke; J L Zehnder; C D Jones; A Milatovich-Cherry; P J Cornbleet
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

3.  Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node.

Authors:  Sanjay Mukhopadhyay; Joseph Readling; Philip D Cotter; Anthony E Shrimpton; Jagmohan S Sidhu
Journal:  Hum Pathol       Date:  2005-05       Impact factor: 3.466

Review 4.  Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations.

Authors:  C M Flaitz; C M Nichols; D M Walling; M J Hicks
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

5.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

6.  CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.

Authors:  J Teruya-Feldstein; E Chiao; D A Filippa; O Lin; R Comenzo; M Coleman; C Portlock; A Noy
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

7.  Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.

Authors:  Francisco Vega; Chung-Che Chang; Leonard J Medeiros; Mark M Udden; Jeong Hee Cho-Vega; Ching-Ching Lau; Chris J Finch; Regis A Vilchez; David McGregor; Jeffrey L Jorgensen
Journal:  Mod Pathol       Date:  2005-06       Impact factor: 7.842

Review 8.  Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature.

Authors:  Fan Lin; Kai Zhang; Albert T Quiery; Jeffrey Prichard; Conrad Schuerch
Journal:  Arch Pathol Lab Med       Date:  2004-05       Impact factor: 5.534

9.  A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.

Authors:  Michio Sawada; Hisashi Tsurumi; Toshiki Yamada; Takeshi Hara; Kenji Fukuno; Hideko Goto; Masahito Shimizu; Senji Kasahara; Takeshi Yoshikawa; Nobuhiro Kanemura; Masami Oyama; Tsuyoshi Takami; Hisataka Moriwaki
Journal:  Eur J Haematol       Date:  2002-06       Impact factor: 2.997

10.  Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Authors:  Lluís Colomo; Florence Loong; Susana Rives; Stefania Pittaluga; Antonio Martínez; Armando López-Guillermo; Jesús Ojanguren; Vicens Romagosa; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

View more
  1 in total

Review 1.  Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.

Authors:  Hirotaka Mori; Masahiko Fukatsu; Hiroshi Ohkawara; Yuka Oka; Yuki Kataoka; Shunsuke Taito; Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2021-08-30       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.